rapid
detect
viralspecif
antibodi
elisa
vet
iunol
immunopathol
develop
three
separ
rapid
elisa
detect
antibodi
host
serum
three
differ
virus
describ
includ
direct
antigen
assay
use
enzym
label
anticanin
ig
detect
antibodi
canin
parvoviru
competit
elisa
use
felin
infecti
periton
virusspecif
monoclon
antibodi
label
enzym
competit
elisa
use
equin
infecti
anemia
virusspecif
monoclon
antibodi
enzym
label
antigen
p
util
benefit
three
approach
emphas
detect
antibodi
specif
pathogen
proven
diagnost
signific
number
viral
bacteri
diseas
varieti
assay
includ
serum
neutral
sn
hemagglutin
inhibit
hi
immunodiffus
id
other
routin
use
measur
presenc
specif
type
antibodi
test
rapidli
replac
sensit
faster
test
elisa
western
blot
sinc
detect
actual
viru
difficult
low
quantiti
viru
present
life
cycl
viru
rel
clinic
symptom
inaccessibilti
infect
tissu
presenc
viralspecif
antibodi
often
use
fingerprint
viral
infect
recent
exampl
applic
htlviiilav
test
hlviii
depend
monitor
infect
presenc
antibodi
rather
antigen
antibodi
screen
also
use
determin
immun
suscept
viral
infect
import
compon
vaccin
develop
test
use
develop
number
elisa
rapid
detect
viralspecif
antibodi
associ
number
signific
anim
diseas
approach
combin
rel
pure
antigen
prepar
monoclon
antibodi
direct
competit
assay
format
assay
proven
rapid
sensit
highli
specif
use
monitor
exposur
immun
suscept
infect
one
primari
caus
vaccin
failur
presenc
matern
antibodi
develop
improv
vaccin
engend
extrem
high
level
protect
antibodi
problem
significantli
increas
case
canin
parvoviru
cpv
clearli
demonstr
matern
antibodi
prevent
immun
puppi
increas
level
matern
antibodi
may
prevent
proper
vaccin
even
beyond
week
age
acr
et
al
pollock
carmichael
sinc
cpv
infect
primarili
diseas
younger
anim
especi
import
puppi
properli
vaccin
presenc
neutral
antibodi
sn
cpv
serum
use
measur
suscept
dog
infect
pollock
carmichael
gener
hi
titer
sn
titer
protect
howev
hi
sn
result
subject
interassay
procedur
variat
requir
sever
day
perform
wallac
et
al
overcom
problem
speed
variabl
rapid
elisa
develop
detect
presenc
antibodi
cpv
fiscu
et
al
test
compon
optim
result
close
parallel
observ
hi
sn
assay
provid
rapid
assay
immun
cpv
infect
assay
design
indic
figur
assay
measur
direct
bind
antibodi
antigen
bound
directli
solid
phase
compon
test
case
microtit
well
minim
number
individu
step
test
perform
simultan
incub
canin
serum
anticanin
ig
enzym
conjug
ensur
specif
bind
viru
purifi
concentr
remov
low
molecular
weight
compon
growth
medium
success
centrifug
sucros
ww
equilibrium
cesium
chlorid
viru
essenti
pure
judg
sdspage
silver
stain
high
yield
nearli
ident
antigen
viru
use
felin
panleukopenia
viru
rather
parvoviru
strain
canin
origin
abl
detect
canin
ig
bound
viru
monoclon
antibodi
develop
recogn
canin
ig
bound
viru
hybridoma
supernat
initi
screen
canin
ig
posit
clone
rescreen
canin
ig
bound
viru
microtit
well
thu
antibodi
wash
dilut
canin
serum
enzyconjug
anticanin
igg
monoclon
antibodi
ad
simultan
cpv
coat
well
incub
min
substrat
ad
color
chang
observ
min
select
correct
specif
would
also
use
predesign
assay
format
compon
assay
optim
provid
maximum
discrimin
posit
neg
sera
fiscu
et
al
includ
optim
type
microtit
well
coat
block
buffer
dilut
buffer
sera
enzym
conjug
method
monoclon
antibodi
wash
buffer
time
incub
result
compar
eightynin
sera
sn
elisa
shown
tabl
cut
taken
minimum
level
necessari
protect
immun
elisa
sensit
discord
elisa
result
sinc
separ
sera
repeatedli
assay
either
time
show
reproduc
elisa
discrep
may
account
variabl
sn
assay
one
two
dilut
either
direct
overal
good
correl
sn
elisa
elisa
use
rapid
screen
monitor
level
immun
cpv
develop
fipvantibodi
base
elisa
strategi
outlin
cpv
figur
follow
unfortun
result
highli
irreproduc
poor
correl
either
clinic
sign
ifa
result
obtain
direct
antigen
assay
approach
abandon
attempt
made
util
seri
coronavirusspecif
monoclon
antibodi
competit
elisa
format
fiscu
et
al
repres
schemat
figur
seri
monoclon
antibodi
develop
character
reactiv
elisa
figur
immunoblot
figur
competit
elisa
three
repres
antibodi
chosen
high
elisa
titer
one
three
major
viral
compon
envelop
glycoprotein
el
n
nucleocapsid
protein
peplom
protein
specif
monoclon
antibodi
offer
clear
advantag
disadvantag
develop
competit
assay
monoclon
natur
antibodi
use
signal
assay
ensur
highli
specif
result
system
also
easili
manipul
optim
sensit
major
disadvantag
one
epitop
analyz
competit
assay
may
repres
overal
immun
respons
anim
viru
constraint
antibodi
recogn
three
major
viral
compon
test
number
sera
experiment
natur
infect
cat
test
use
protocol
describ
glycoprotein
gave
best
correl
ifa
fiscu
et
al
clinic
histori
cat
repres
celisa
profil
one
experiment
infect
cat
one
control
cat
shown
figur
eiaagid
initi
seen
prime
candid
convers
rapid
elisa
although
agio
highli
sensit
specif
test
requir
hour
perform
subject
reader
error
interpret
weakli
reactiv
sampl
equin
immun
respons
eia
viru
well
character
infect
hors
develop
antibodi
highli
conserv
abund
viral
core
protein
issel
coggin
procedur
growth
viru
purif
protein
develop
montelaro
et
al
enzym
conjug
equin
virusspecif
polyclon
monoclon
antibodi
use
detect
molecul
observ
sma
l
percentag
agid
neg
hors
sera
gave
consist
posit
result
direct
antigen
elisa
hors
sera
react
strongli
contamin
bovin
serum
albumin
bsa
agid
hypothes
sera
recogn
small
amount
bsa
less
remain
purifi
antigen
prepar
matsushita
et
al
circumv
problem
bank
monoclon
antibodi
prepar
antibodi
conjug
horseradish
peroxidas
use
develop
competit
elisa
similar
previous
describ
fip
figur
although
approach
prove
superior
direct
antigen
elisa
sever
hors
sera
still
gave
fals
positiw
result
use
agid
standard
hypothes
bsaspecif
equin
antibodi
bind
bsa
microtit
well
interf
bind
enzymelabel
monoclon
antibodi
result
fals
competit
circumv
problem
assay
combin
specif
monoclon
antibodi
abil
purifi
enzymelabel
protein
develop
figur
monoclon
antibodi
specif
select
abil
bind
microtit
well
captur
enzymelabel
contamin
protein
label
one
advantag
use
monoclon
antibodi
gener
lower
affin
thu
simultan
competit
bind
antigen
hors
serum
bind
effici
solut
label
antigen
competit
readili
discern
result
test
seri
field
sampl
eia
celisa
shown
approxim
time
sensit
agid
base
compar
end
point
dilut
agid
end
point
dilut
give
competit
celisa
result
also
easili
visual
one
interest
facet
eia
celisa
assay
also
use
measur
eia
antigen
viru
present
sera
bound
monoclon
antibodi
compet
enzymelabel
titrat
studi
shown
less
ng
viru
detect
assay
studi
underway
examin
whether
initi
stage
infect
viremia
occur
prior
onset
immun
respons
detect
three
approach
develop
elisa
viral
specif
antibodi
describ
although
differ
greatli
actual
assay
format
share
sever
basic
compon
first
use
monoclon
antibodi
provid
excel
specif
sensit
key
select
appropri
monoclon
antibodi
case
design
screen
procedur
stimul
actual
util
antibodi
particular
assay
format
allow
one
rapidli
select
optim
right
antibodi
larg
number
monoclon
antibodi
usual
gener
immunogen
molecul
second
puriti
biochem
character
viru
play
major
role
develop
elisa
although
fairli
simpl
structur
three
virus
describ
antigen
complex
case
fip
exampl
import
first
identifi
protein
recogn
felin
immun
system
although
alreadi
known
eiav
puriti
protein
paramount
success
develop
eiacelisa
clearli
import
develop
viral
purif
scheme
maxim
yield
diagnost
import
antigen
third
compon
elisa
must
optim
key
paramet
includ
solid
phase
coat
procedur
solid
phase
enzym
conjug
method
sampl
diluent
buffer
wash
buffer
time
temperatur
incub
although
individu
paramet
may
slightli
improv
perform
test
combin
may
well
prove
quit
signific
final
appar
one
assay
format
suitabl
wide
rang
viralspecif
antibodi
test
type
structur
well
life
cycl
virus
vari
greatli
thu
wise
assum
strategi
use
develop
assay
clever
divers
viru
